期刊文献+

一种单克隆抗体的电荷异质体分析 被引量:1

Analysis of charge variants of a monoclonal antibody
原文传递
导出
摘要 目的对抗程序性死亡受体-1(programmed death-1,PD-1)单克隆抗体的电荷异质体进行结构鉴别及生物学功能分析。方法通过检测抗PD-1单克隆抗体经专一性蛋白酶(唾液酸酶及羧肽酶)酶切前后的变化,初步确认电荷异质体的种类。采用阳离子交换色谱对电荷异质体进行分离和收集,经联用液相色谱-质谱(LC-MS)法分析电荷异质体各组分的组成;通过抑制抗原与配体相互作用影响NFAT荧光素酶报告基因表达的方法确定电荷异质体的生物学功能。结果碱性异质体含量较少,主要变化为重链N-末端谷氨酰胺未环化;酸性异质体主要变化为重链N383脱氨化和糖链末端唾液酸化。各异质体的生物学活性为89%~102%。结论抗PD-1单克隆抗体电荷异质体大部分修饰位点均远离互补决定区(complementary determining region,CDR),且在体外生物学活性方面差异较小。 Objective To identify the structure and analyze the function of charge variants of a monoclonal antibody(m Ab)against programmed death-1(PD-1)receptor. Methods The charge heterogeneity change of anti-PD-1 mAb was primarily confirmed through digestion with specific proteases(sialidase and carboxypeptidase). The charge variants were isolated and collected by cation-exchange chromatography(CEX-HPLC), analyzed for the composition of various fractions by liquid chromatography-mass spectrometry(LC-MS), and determined for in vitro biological activity via bioluminescent reporter-based antigen/ligand blockade bioassay. Results Low levels of basic charge variants were observed, which were mainly due to un-cyclization of N-terminal glutamide in heavy chain. Acidic charge variants were mainly induced by N383 deamination and N-glycan sialylation in heavy chain. The biological activities of various fractions were 89% ~ 102%.Conclusion Most modification sites were away from complementary determining region(CDR), and thus no significant difference was observed in the biological activities of various charge variants of anti-PD-1 mAb.
出处 《中国生物制品学杂志》 CAS CSCD 2017年第8期828-832,共5页 Chinese Journal of Biologicals
关键词 单克隆抗体 电荷异质体 离子交换色谱 联用液相色谱-质谱法 生物学活性 Monoclonal antibody(mAb) Charge variants Ion exchange chromatography Liquid chromatography-mass spectrometry(LC-MS) Biological activity
  • 相关文献

参考文献1

二级参考文献12

  • 1Liu H, Gaza-Bulseco G, Faldu D, et al. Heterogeneity of mono- clonal antibodies [ J ]. J Pharm Sci,2008,97 (7) :2426-2447.
  • 2Du Y, Walsh A, Ehrick R, et al. Chromatographic analysis of the. acidic and basic species of recombinant monoclonal antibodies [J]. MAbs,2012,4 (5) :578-585.
  • 3Read EK, Park JT, Brorson KA. Industry and regulatory experience of the glycosylation of monoclonal antibodies[ J]. Biotechnol Appl Biochem,2011,58(4) :213-219.
  • 4Antes B, Amon S, Rizzi A, et al. Analysis of lysine clipping of a humanized lewis-Y specific IgG antibody and its relation to Fc-me- diated effector function[ J]. J Chromatogr B, 2007,852 (1/2) : 250 -256.
  • 5Scallon B J, Tam SH, McCarthy SG, et al. Higher levels of sialylat- ed Fc glycans in immunoglobulin G molecules can adversely im- pact functionality[J]. Mol Immunol,2007,44 (7) :1524-1534.
  • 6Naso MF,Tam SH,Seallon BJ,et al. Engineering host cell lines to reduce terminal sialylation of secreted antibodies [ J ]. MAbs, 2010,2 (5) :519-527.
  • 7Ghaderi D, Taylor RE, Padler-Karavani V, et al. Implications of the presence of N-glyeolylneuraminic acid in recombinant thera- peutic glycoproteins[ J]. Nat Biotechnol,2010,28 (8) :863-867.
  • 8Yan B, Steen S, Hambly D, et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant mono- clonal antibody IgG1 heavy chain[J]. J Pharm Sci, 2009,98 (10) :3509-3521.
  • 9Du Y, Walsh A, Ehrick R, et al. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies [ J]. MAbs,2012,4 (5) :578-585.
  • 10Sosic Z, Houde D, Blum A, et al. Application of imaging capillary IEF for characterization and quantitative analysis of recombinant protein charge heterogeneity[J]. Electrophoresis, 2008, 29 (21) :4368-4376.

共引文献8

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部